Radiopharm Theranostics Limited (RADX) News
Follow Radiopharm Theranostics Limited (RADX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Radiopharm Theranostics reports positive Phase 1 imaging data for RAD301
Radiopharm Theranostics said Phase 1 imaging trial data for RAD301 in pancreatic ductal adenocarcinoma patients was positive.
EQUITY | Sep 09, 2026, 11:00 AM UTC
L
RADX doses first patient in second Phase 1/2a BetaBart cohort
Radiopharm Theranostics (RADX) dosed the first patient in the second cohort of its Phase 1/2a trial of BetaBart (RV-01) in B7-H3 expressing solid tumors.
EQUITY | Aug 26, 2026, 11:00 AM UTC
M
Radiopharm Theranostics gets positive DSMC recommendation for 177Lu-RAD202 trial
Radiopharm Theranostics says its Data Safety and Monitoring Committee issued a positive recommendation to advance to Cohort 4 in the Phase 1 HEAT clinical trial of 177Lu-RAD202.
EQUITY | Aug 20, 2026, 11:00 AM UTC
H
RADX to meet U.S. FDA on RAD 101 Phase 3 trial design
Radiopharm Theranostics (RADX) says it will meet with the U.S. FDA to align on pivotal Phase 3 trial design for RAD 101 in the diagnosis of brain metastases.
REGULATION | Aug 17, 2026, 11:30 AM UTC
M
RADX Reports Business Update
RADX releases business update
EQUITY | Jul 31, 2026, 11:00 AM UTC
H
US Stocks Mixed; American Express Shares Fall Following Q2 Results
U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 0.2% on Friday. Following the market opening Friday, the Dow traded up 0.17% to 51,799.17 while the NASDAQ declined 0.15% to 25,099.23. The S
MACRO | Jul 24, 2026, 01:45 PM UTC